Insiders · Profile

Bashan Dror

PRESIDENT AND CEO at Protalix BioTherapeutics. Filing since 11 Apr 2022. CIK 0001781450

Company
Date
Role
Action
Shares
Amount
Of holding
19 Dec 2025
PRESIDENT AND CEO
Bought
56,000
$101.36K
42.3%
19 Oct 2023
PRESIDENT AND CEO
Bought
64,516
$90.48K
94.9%
11 Apr 2022
President and CEO
Bought
68,000
$102.00K
opened
3 decisions on file.